Advancements in Nanocarrier Production Techniques and Methods for Enhanced Targeted Delivery of Drug: A Comprehensive Review.

IF 3
Atish Kumar S Mundada, Lokesh P Kothari, Kuldeep Vinchurkar, Saloni Yadav, Arprita Malhan, Mridul Guleria, Sudarshan Singh
{"title":"Advancements in Nanocarrier Production Techniques and Methods for Enhanced Targeted Delivery of Drug: A Comprehensive Review.","authors":"Atish Kumar S Mundada, Lokesh P Kothari, Kuldeep Vinchurkar, Saloni Yadav, Arprita Malhan, Mridul Guleria, Sudarshan Singh","doi":"10.2174/0115672018379860250722161458","DOIUrl":null,"url":null,"abstract":"<p><p>Nanotechnology has transformed drug delivery systems, leading to the creation of various nanocarriers that offer significant advantages over traditional methods. This review explores key techniques and methods for producing nanocarriers like liposomes, niosomes, dendrimers, nanocapsules, carbon nanotubes, polymeric micelles, and solid lipid nanoparticles. Operating within the nanoscale range (1-100 nm), these nanocarriers enhance drug efficacy, reduce side effects, and improve bioavailability. Liposomes are generated using methods, such as the Bangham procedure, solvent injection, and microfluidic channels. Nanocarriers have become fundamental to sophisticated drug delivery systems, providing improved precision, regulated release, and targeted therapeutic administration. Innovative methods, such as microfluidics and nanoprecipitation, have enhanced the scalability and consistency of nanocarriers, while progress in surface engineering, including ligand conjugation and stimuli-responsive coatings, facilitates improved targeting and controlled drug release. The advancement of biocompatible and biodegradable nanomaterials, including polymeric nanoparticles, liposomes, and dendrimers, has broadened the clinical utility of nanocarriers, especially in oncology, neurology, and gene therapy. This review underscores the versatility and potential of these nanocarriers in advancing drug delivery, emphasizing their capacity for targeted, efficient, and controlled therapeutic interventions.</p>","PeriodicalId":94287,"journal":{"name":"Current drug delivery","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115672018379860250722161458","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Nanotechnology has transformed drug delivery systems, leading to the creation of various nanocarriers that offer significant advantages over traditional methods. This review explores key techniques and methods for producing nanocarriers like liposomes, niosomes, dendrimers, nanocapsules, carbon nanotubes, polymeric micelles, and solid lipid nanoparticles. Operating within the nanoscale range (1-100 nm), these nanocarriers enhance drug efficacy, reduce side effects, and improve bioavailability. Liposomes are generated using methods, such as the Bangham procedure, solvent injection, and microfluidic channels. Nanocarriers have become fundamental to sophisticated drug delivery systems, providing improved precision, regulated release, and targeted therapeutic administration. Innovative methods, such as microfluidics and nanoprecipitation, have enhanced the scalability and consistency of nanocarriers, while progress in surface engineering, including ligand conjugation and stimuli-responsive coatings, facilitates improved targeting and controlled drug release. The advancement of biocompatible and biodegradable nanomaterials, including polymeric nanoparticles, liposomes, and dendrimers, has broadened the clinical utility of nanocarriers, especially in oncology, neurology, and gene therapy. This review underscores the versatility and potential of these nanocarriers in advancing drug delivery, emphasizing their capacity for targeted, efficient, and controlled therapeutic interventions.

纳米载体生产技术和药物靶向递送方法的研究进展综述。
纳米技术已经改变了药物输送系统,导致了各种纳米载体的产生,这些纳米载体比传统方法提供了显著的优势。本文综述了制备纳米载体的关键技术和方法,如脂质体、乳质体、树状大分子、纳米胶囊、碳纳米管、聚合物胶束和固体脂质纳米颗粒。这些纳米载体在纳米尺度范围(1-100纳米)内工作,增强了药物疗效,减少了副作用,提高了生物利用度。脂质体是通过诸如Bangham程序、溶剂注射和微流体通道等方法生成的。纳米载体已成为复杂药物输送系统的基础,提供更高的精度,调节释放和靶向治疗管理。创新的方法,如微流体和纳米沉淀,增强了纳米载体的可扩展性和一致性,而表面工程的进展,包括配体偶联和刺激响应涂层,有助于改善靶向性和控制药物释放。生物相容性和可生物降解的纳米材料,包括聚合纳米颗粒、脂质体和树状大分子的进步,扩大了纳米载体的临床应用,特别是在肿瘤、神经病学和基因治疗方面。这篇综述强调了这些纳米载体在推进药物递送方面的多功能性和潜力,强调了它们在靶向、高效和可控的治疗干预方面的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信